Results
A total of 114 subjects were recruited: a group of 57 AD adult patients
(mean age ± std. dev., 34.28 years ± 13.07; 27 males; range, 18–67
years) with a mean disease duration of 23.46 ± 12.12 and a control group
of 57 healthy adults (34.39 years ± 13.09; 27 males; 18–67 years)
without skin diseases.
Clinical patterns concerning AD onset and course, clinical phenotype,
current AD treatments, comorbidities, and clinical-oriented (EASI) and
patient-oriented (POEM) severity of AD are shown in Table 1.